èšåºæ®µéã®ãã«ã¹ã±ã¢äŒæ¥ã§ãã Kaleido Biosciences, Inc. ã¯ããã€ã¯ããã€ãªãŒã 代è¬çæ³ãéçºããŠããŸããå瀟ã¯ãå°¿çŽ ãµã€ã¯ã«ç°åžžçæ£è
ã®æ²»çã®ããã® KB195ãæœ°çæ§å€§è
žçæ²»çã®ããã® KB295ãèæ§è³çæ²»çã®ããã® KB174ãããã³ COVID-19 çŸæ£æ²»çã®ããã® KB109 ãéçºããŠããŸãããŸããå
ç«è
«çåŠãå¿è¡ç®¡ä»£è¬ããã³èèçŸæ£ã®æ²»çããã°ã©ã ãéçºããŠããŸããå瀟ã¯ãã®ã¥ã¹ã¿ãŒãŽã»ã«ãã·ãŒããã»ã³ã¿ãŒãã¯ã·ã³ãã³å€§åŠå»åŠéšãããã³ã€ã³ã»ã³ãšååå¥çŽãçµãã§ããŸãããŸããæ
¢æ§é塿§èºçŸæ£æ£è
ã察象㫠KB109 ãç ç©¶ãããããCOPD 財å£ãšæŠç¥çææºãçµãã§ããŸããå瀟㯠2015 幎ã«èšç«ãããããµãã¥ãŒã»ããå·ã¬ãã·ã³ãã³ã«æ¬ç€Ÿã眮ããŠããŸãã